NATIONAL HEALTHCARE CORP 10-Q

Item 1. Financial Statements. NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Statements of Operations (in thousands, except share and per share amounts) (unaudited) Three Months Ended March 31 2026 2025 Revenues: Net patient revenues $ 369,805 $ 361,607 Other revenues 12,016 12,090 Net operating revenues 381,821 373,697 Cost and expenses: Salaries, wages, and benefits 235,074 228,130 Other operating 91,237 92,457 Facility rent 11,643 11,365 Depreciation and amortization 11,614 10,978 Total costs and expenses 349,568 342,930 Income from operations 32,253 30,767 Other income (expense): Non–operating income 3,757 4,079 Interest expense ( 269 ) ( 2,106 ) Unrealized gains on marketable equity securities 9,074 10,982 Income before income taxes 44,815 43,722 Income tax provision ( 8,712 ) ( 11,432 ) Net income 36,103 32,290 Net income attributable to noncontrolling interest ( 246 ) ( 85 ) Net income attributable to National HealthCare Corporation $ 35,857 $ 32,205 Earnings per share attributable to National HealthCare Corporation stockholders: Basic $ 2.31 $ 2.09 Diluted $ 2.27 $ 2.07 Weighted average common shares outstanding: Basic 15,541,634 15,438,306 Diluted 15,770,507 15,575,752 The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 3 Table of Contents NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Statements of Comprehensive Income (unaudited – in thousands) Three Months Ended March 31 2026 2025 Net income $ 36,103 $ 32,290 Other comprehensive income/(loss): Unrealized gains/(losses) on investments in marketable debt securities ( 1,092 ) 1,594 Reclassification adjustment for realized losses on sales of marketable debt securities 11 – Income tax (expense)/benefit related to items of other comprehensive income 162 ( 204 ) Other comprehensive income/(loss), net of tax ( 919 ) 1,390 Net income attributable to noncontrolling interest ( 246 ) ( 85 ) Comprehensive income attributable to National HealthCare Corporation $ 34,938 $ 33,595 The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 4 Table of Contents NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Balance Sheets (in thousands) March 31, 2026 December 31, 2025 unaudited Assets Current Assets: Cash and cash equivalents $ 85,526 $ 92,829 Restricted cash and cash equivalents, current portion 19,605 18,118 Marketable equity securities 172,826 162,972 Restricted marketable equity securities 16,624 17,197 Restricted marketable debt securities, current portion 16,991 18,062 Accounts receivable 137,742 139,002 Inventories 9,150 7,795 Prepaid expenses and other assets 7,112 5,845 Total current assets 465,576 461,820 Property and Equipment: Property and equipment, at cost 1,318,245 1,308,891 Accumulated depreciation and amortization ( 646,422 ) ( 635,094 ) Net property and equipment 671,823 673,797 Other Assets: Restricted cash and cash equivalents, less current portion 1,197 1,240 Restricted marketable debt securities, less current portion 105,841 105,231 Deposits and other assets 7,546 7,478 Operating lease right-of-use assets 39,787 47,778 Goodwill 170,478 170,478 Intangible assets 19,864 19,864 Investments in unconsolidated companies 41,982 38,733 Total other assets 386,695 390,802 Total assets $ 1,524,094 $ 1,526,419 The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 5 Table of Contents NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Balance Sheets (continued) (in thousands, except share and per share amounts) March 31, 2026 December 31, 2025 unaudited Liabilities and Stockholders ’ Equity Current Liabilities: Trade accounts payable $ 21,371 $ 22,767 Operating lease liabilities, current portion 26,018 33,611 Accrued payroll 109,575 103,917 Amounts due to third party payors 14,062 13,739 Accrued risk reserves, current portion 36,595 36,180 Other current liabilities 33,215 25,977 Dividends payable 9,989 9,941 Long-term debt due within one year – 7,500 Total current liabilities 250,825 253,632 Long-term debt – 32,500 Operating lease liabilities, less current portion 13,296 13,461 Accrued risk reserves, less current portion 89,905 85,415 Refundable entrance fees 5,992 6,178 Deferred income taxes 45,250 42,687 Other noncurrent liabilities 22,212 18,031 Total liabilities 427,480 451,904 Equity: Common stock, $ .01 par value; 45,000,000 shares authorized; 15,607,204 and 15,536,427 shares, respectively, issued and outstanding 156 155 Capital in excess of par value 233,639 236,412 Retained earnings 858,852 832,984 Accumulated other comprehensive loss ( 1,698 ) ( 779 ) Total National HealthCare Corporation stockholders’ equity 1,090,949 1,068,772 Noncontrolling interest 5,665 5,743 Total equity 1,096,614 1,074,515 Total liabilities and equity $ 1,524,094 $ 1,526,419 The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 6 Table of Contents NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Statements of Cash Flows (unaudited – in thousands) Three Months Ended March 31 2026 2025 Cash Flows From Operating Activities: Net income $ 36,103 $ 32,290 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 11,614 10,978 Equity in losses of unconsolidated investments 346 – Unrealized gains on marketable equity securities ( 9,074 ) ( 10,982 ) Gains on sale of marketable securities ( 173 ) ( 241 ) Deferred income taxes 2,725 1,356 Stock–based compensation 1,280 1,027 Changes in operating assets and liabilities: Accounts receivable 1,260 ( 6,416 ) Inventories ( 1,355 ) 960 Prepaid expenses and other assets ( 1,335 ) 445 Operating lease obligations 233 175 Trade accounts payable ( 1,396 ) ( 3,847 ) Accrued payroll 5,658 3,541 Amounts due to third party payors 323 ( 1,454 ) Accrued risk reserves 4,905 4,581 Other current liabilities 7,238 5,919 Other noncurrent liabilities 4,181 923 Net cash provided by operating activities 62,533 39,255 Cash Flows From Investing Activities: Purchases of property and equipment ( 9,640 ) ( 6,137 ) Investments in unconsolidated companies ( 3,594 ) ( 2,419 ) Collections of notes receivable – 7 Purchases of marketable securities ( 10,938 ) ( 11,062 ) Proceeds from sale of marketable securities 10,284 12,288 Net cash used in investing activities ( 13,888 ) ( 7,323 ) Cash Flows From Financing Activities: Repayments under credit facility ( 40,000 ) ( 3,000 ) Dividends paid to common stockholders ( 9,941 ) ( 9,420 ) Issuance of common stock 12,268 1,278 Repurchase of common shares ( 16,321 ) ( 1,722 ) Noncontrolling interest distributions ( 324 ) – Entrance fee deposits (refunds) ( 186 ) 171 Net cash used in financing activities ( 54,504 ) ( 12,693 ) Net Increase/(Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents ( 5,859 ) 19,239 Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning of Period 112,187 96,922 Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, End of Period $ 106,328 $ 116,161 Balance Sheet Classifications: Cash and cash equivalents $ 85,526 $ 90,386 Restricted cash and cash equivalents 20,802 25,775 Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents $ 106,328 $ 116,161 The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 7 Table of Contents NATIONAL HEALTHCARE CORPORATION Interim Condensed Consolidated Statements of Stockholders ’ Equity (in thousands, except share and per share amounts) (unaudited) For the three months ended March 31, 2026 : Common Stock Capital in Excess of Retained Accumulated Other Comprehensive Non- controlling Total Stockholders’ Shares Amount Par Value Earnings Loss Interest Equity Balance at January 1, 2026 15,536,427 $ 155 $ 236,412 $ 832,984 $ ( 779 ) $ 5,743 $ 1,074,515 Net income – – – 35,857 – 246 36,103 Distributions attributable to noncontrolling interest – – – – – ( 324 ) ( 324 ) Other comprehensive loss – – – – ( 919 ) – ( 919 ) Stock–based compensation – – 1,280 – – – 1,280 Shares sold – options exercised 168,497 1 12,268 – – – 12,269 Repurchase of common shares ( 97,720 ) – ( 16,321 ) – – – ( 16,321 ) Dividends declared to common stockholders ($ 0.64 per share) – – – ( 9,989 ) – – ( 9,989 ) Balance at March 31, 2026 15,607,204 $ 156 $ 233,639 $ 858,852 $ ( 1,698 ) $ 5,665 $ 1,096,614 For the three months ended March 31, 2025: Common Stock Capital in Excess of Retained Accumulated Other Comprehensive Non- controlling Total Stockholders’ Shares Amount Par Value Earnings Loss Interest Equity Balance at January 1, 2025 15,450,003 $ 154 $ 232,530 $ 752,193 $ ( 4,716 ) $ 3,002 $ 983,163 Net income – – – 32,205 – 85 32,290 Other comprehensive income – – – – 1,390 – 1,390 Stock–based compensation – – 1,027 – – – 1,027 Shares sold – options exercised 32,262 – 1,278 – – – 1,278 Repurchase of common shares ( 17,409 ) – ( 1,722 ) – – – ( 1,722 ) Dividends declared to common stockholders ($ 0.61 per share) – – – ( 9,444 ) – – ( 9,444 ) Balance at March 31, 2025 15,464,856 $ 154 $ 233,113 $ 774,954 $ ( 3,326 ) $ 3,087 $ 1,007,982 T he accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements. 8 Table of Contents NATIONAL HEALTHCARE CORPORATION Notes to Interim Condensed Consolidated Financial Statements March 31, 2026 (unaudited) Note 1 – Description of Business National HealthCare Corporation (“NHC” or the “Company”) is a leading provider of senior health care services. As of March 31, 2026, we operate or manage, through certain affiliates, 80 skilled nursing facilities with a total of 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. We operate specialized care units within certain of our healthcare centers such as Alzheimer's disease care units and sub-acute nursing units. In addition, we provide insurance services, management and accounting services, and we lease properties to operators of skilled nursing and assisted living facilities. We operate in 9 states and are located primarily in the southeastern United States. Note 2 – Summary of Significant Accounting Policies The listing below is not intended to be a comprehensive list of all our significant accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by U.S. generally accepted accounting principles (“GAAP”), with limited need for management’s judgment in their application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. See our audited December 31, 2025 consolidated financial statements and notes thereto which contain accounting policies and other disclosures required by U.S. GAAP. Our audited December 31, 2025 consolidated financial statements are available at our web site: www.nhccare.com . Basis of Presentation The unaudited interim condensed consolidated financial statements to which these notes are attached include all normal, recurring adjustments which are necessary to fairly present the financial position, results of operations and cash flows of NHC. All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements include the accounts of all entities controlled by NHC. The Company presents noncontrolling interest within the equity section of its consolidated balance sheets. The Company presents the amount of consolidated net income that is attributable to NHC and the noncontrolling interest in its consolidated statements of operations. We assume that users of these interim financial statements have read or have access to the audited December 31, 2025 consolidated financial statements and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context. Accordingly, footnotes and other disclosures which would substantially duplicate the disclosure contained in our most recent annual report to stockholders have been omitted. This interim financial information is not necessarily indicative of the results that may be expected for a full year for a variety of reasons. Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period. Net Patient Revenues and Accounts Receivable Net patient revenues are derived from services rendered to patients for skilled and intermediate nursing, rehabilitation therapy, assisted living and independent living, home health care services, hospice services, and behavioral health services. Net patient revenue is reported at the amount that reflects the consideration to which the Company expects to be entitled in exchange for providing patient services. These amounts are due from patients, governmental programs, and other third -party payors, and include variable consideration for retroactive revenue adjustments due to settlement of audits, reviews, and investigations. The Company recognizes revenue as its performance obligations are completed. Routine services are treated as a single performance obligation satisfied over time as services are rendered. These routine services represent a bundle of services that are not capable of being distinct. The performance obligations are satisfied over time as the patient simultaneously receives and consumes the benefits of the healthcare services provided. Additionally, there may be ancillary services which are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time when those services are rendered. 9 Table of Contents We determine the transaction price based on contractually agreed-upon amounts or rates, adjusted for estimates of variable consideration, such as implicit price concessions. We utilize the expected value method to determine the amount of variable consideration that should be included to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. We constrain the transaction price, such that net revenues are recorded only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in the future. If actual amounts of consideration ultimately received differ from our estimates, we adjust these estimates, which would affect net revenue in the period such variances become known. Other Revenues Other revenues include revenues from the provision of insurance services to other healthcare providers, management and accounting services to other healthcare providers, and rental income. Our insurance revenues consist of premiums that are generally paid in advance and then amortized into income over the policy period. We charge for management services based on a percentage of net revenues. We charge for accounting services based on a monthly fee or a fixed fee per bed of the healthcare center under contract. We record other revenues as the performance obligations are satisfied based on the terms of our contractual arrangements. We recognize rental income based on the terms of our operating leases. Under certain of our leases, we receive variable rent, which is based on the increase in revenues of a lessee over a base year. We recognize variable rent annually or monthly, as applicable, when, based on the actual revenue of the lessee is earned. Segment Reporting In accordance with the provisions of Accounting Standards Codification ("ASC") 280, Segment Reporting , the Company is required to report financial and descriptive information about its reportable operating segments. The Company has two reportable operating segments: ( 1 ) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals, and ( 2 ) homecare and hospice services. The Company also reports an "all other" category that includes revenues from rental income, management and accounting services fees, insurance services, and cost of the corporate office. See Note 6 for further disclosure of the Company’s operating segments. Other Operating Expenses Other operating expenses include the costs of care and services that we provide to the residents of our facilities and the costs of maintaining our facilities. Our primary patient care costs include drugs, medical supplies, purchased professional services, food, and professional liability insurance and licensing fees. The primary facility costs include utilities and property insurance. General and Administrative Costs With the Company being a healthcare provider, the majority of our expenses are "cost of revenue" items. Costs that could be classified as "general and administrative" by the Company would include its corporate office costs, excluding stock-based compensation, which were $ 5,843,000 and $ 6,632,000 for the three months ended March 31, 2026 and 2025, respectively. Long-Term Leases The Company’s lease portfolio primarily consists of operating real estate leases for certain skilled nursing facilities, assisted and independent living facilities, homecare and hospice offices, and pharmacy warehouses. The original terms of the leases typically range from two to fifteen years. Several of the real estate leases include renewal options which vary in length and may not include specific rent renewal amounts. We determine if an arrangement is a lease at inception of a contract. We determine the lease term by assuming exercise of renewal options that are reasonably certain. The Company records right-of-use assets and liabilities for non-cancelable real estate operating leases with original or remaining lease terms in excess of one year. Leases with a lease term of 12 months or less at inception are not recorded and are expensed on a straight-line basis over the lease term. We recognize lease components and non-lease components together and not as separate parts of a lease for real estate leases. 10 Table of Contents Operating lease right-of-use assets and liabilities are recorded at the present value of the lease payments over the lease term. The present value of the lease payments are discounted using the incremental borrowing rate associated with each lease. The variable components of the lease payment that fluctuate with the operations of a health facility are not included in determining the right-of-use assets and lease liabilities. Rather, these variable components are expensed as incurred. Property and Equipment Property and equipment are recorded at cost. Depreciation is provided by the straight-line method over the expected useful lives of the assets estimated as follows: buildings and improvements, 20 - 40 years and equipment and furniture, 3 - 15 years. Leasehold improvements are amortized over periods that do not exceed the non-cancelable respective lease terms using the straight-line method. Investments in Unconsolidated Companies We use the equity method to account for our investments in joint ventures in which we have the ability to exercise significant influence. Original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses. As of March 31, 2026, the majority of our investments in unconsolidated companies relate to two multi-family developments that are under construction in Franklin, Tennessee and Hermitage, Tennessee. Business Combinations We account for transactions that represent business combinations using the acquisition method of accounting in accordance with ASC 805, Business Combinations. Acquisitions are accounted for as purchases and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized for the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired and liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques. These valuation methods require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates. Goodwill and Other Intangible Assets Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur, or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The Company’s indefinite-lived intangible assets consist of trade names and certificates of need and licenses. The Company reviews indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset is below its carrying amount. Accrued Risk Reserves We are self–insured for risks related to workers’ compensation and general and professional liability insurance. We have two wholly–owned limited purpose insurance companies that insure these risks. The accrued risk reserves include a liability for reported claims and estimates for incurred but unreported claims. Our policy is to engage an external, independent actuary to assist in estimating our exposure for claims obligations (for both asserted and unasserted claims). We reassess our accrued risk reserves on a quarterly basis. Professional liability remains an area of particular concern to us. The long-term care industry has seen an increase in personal injury/wrongful death claims based on alleged negligence by skilled nursing facilities and their employees in providing care to residents. The Company has been, and continues to be, subject to claims and legal actions that arise in the ordinary course of business, including potential claims related to patient care and treatment. A significant increase in the number of these claims, or an increase in the amounts due as a result of these claims could have a material adverse effect on our consolidated financial position, results of operations and cash flows. It is also possible that future events could cause us to make significant adjustments or revisions to these reserve estimates and cause our reported net income to vary significantly from period to period. We are principally self-insured for incidents occurring in all centers owned or leased by us. The coverages include both primary policies and excess policies. In all years, settlements, if any, in excess of available insurance policy limits and our own reserves would be expensed by us. 11 Table of Contents Continuing Care Contracts We have continuing care retirement centers (“CCRC”) within our operations. Residents may enter into continuing care contracts with us. Non-refundable fees are included as a component of the transaction price and are amortized into revenue over the actuarily determined remaining life of the resident, which is the expected period of occupancy by the resident. We pay the refundable portion of our entry fees to residents when they relocate from our community and the apartment is re-occupied. Refundable entrance fees are not included as part of the transaction price and are classified as noncurrent liabilities in our consolidated balance sheets. We also annually estimate the present value of the cost of future services and the use of facilities to be provided to the current CCRC residents and compare that amount with the balance of non-refundable deferred revenue from entrance fees received. If the present value of the cost of future services exceeds the related anticipated revenues, a liability is recorded with a corresponding charge to income. As of March 31, 2026, and December 31, 2025, we have recorded a future service obligation liability in the amount of $ 1,482,000 . This obligation is reflected within other noncurrent liabilities in the interim condensed consolidated balance sheets. Other Noncurrent Liabilities Other noncurrent liabilities include reserves primarily related to various uncertain income tax positions, deferred revenue, and obligations to provide future services to our CCRC residents. Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (“National”) and the non-refundable portion of CCRC entrance fees being amortized over the remaining life expectancies of the residents. Noncontrolling Interest The noncontrolling interest in a subsidiary is presented within total equity in the Company's interim condensed consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to NHC in its interim condensed consolidated statements of operations. The Company’s earnings per share is calculated based on net income attributable to NHC’s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of the subsidiary earnings, contributions, and distributions. Recent Accounting Guidance Not Yet Adopted In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023 - 06, " Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative ," which amends U.S. GAAP to include certain disclosure requirements that are currently required under SEC Regulation S- X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S- X or Regulation S-K. The adoption is not expected to have a material impact on the Company's financial statements as these requirements were previously incorporated under the SEC Regulations. In November 2024, the FASB issued ASU 2024 - 03 " Disaggregation of Income Statement Expenses ," which requires the Company to disaggregate key expense categories such as employee compensation and depreciation within its financial statements. ASU 2024 - 03 is effective for annual periods beginning with the Company's fiscal year 2027, and interim periods with the Company's fiscal year 2028, with early adoption permitted. We are currently evaluating the impact this ASU will have on the company's financial statements and related disclosures. 12 Table of Contents Note 3 – Net Patient Revenues The Company disaggregates revenue from contracts with customers by service type and by payor. Revenue by Service Type The Company’s net patient services can generally be classified into the following two categories: ( 1 ) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals, and ( 2 ) homecare and hospice services (in thousands) . Three Months Ended March 31 2026 2025 Net patient revenues: Inpatient services $ 330,330 $ 325,478 Homecare and hospice services 39,475 36,129 Total net patient revenues $ 369,805 $ 361,607 13 Table of Contents For inpatient and hospice services, revenue is recognized on a daily basis as each day represents a separate contract and performance obligation. For homecare, revenue is recognized when services are provided based on the number of days of service rendered in the period of care or on a per-visit basis. Typically, patients and third -party payors are billed monthly after services are performed or the patient is discharged, and payments are due based on contract terms. As our performance obligations relate to contracts with a duration of one year or less, the Company is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The Company has minimal unsatisfied performance obligations at the end of the reporting period as our patients are typically under no obligation to remain admitted in our facilities or under our care. As the period between the time of service and time of payment is typically one year or less, the Company did not adjust for the effects of a significant financing component. Revenue by Payor Certain groups of patients receive funds to pay the cost of their care from a common source. The following table sets forth sources of net patient revenues for the periods indicated: Three Months Ended March 31 Source 2026 2025 Medicare 31 % 31 % Managed Care 13 % 11 % Medicaid 29 % 31 % Private Pay and Other 27 % 27 % Total 100 % 100 % Medicare covers skilled nursing services for beneficiaries who require nursing care and/or rehabilitation services following a hospitalization of at least three consecutive days. For each eligible day a Medicare beneficiary is in a skilled nursing facility, Medicare pays the facility a daily payment, subject to adjustment for certain factors such as a wage index in the geographic area. The payment covers all services provided by the skilled nursing facility for the beneficiary that day, including room and board, nursing, therapy and drugs, as well as an estimate of capital–related costs to deliver those services. For homecare services, Medicare pays based on the acuity level of the patient and based on periods of care. A period of care is defined as a length of care up to 30 days with multiple continuous periods allowed. The services covered by the payment include all disciplines of care, in addition to medical supplies, within the scope of the home health benefit. For hospice services, Medicare pays a daily rate to cover the hospice’s costs for providing services included in the patient care plan. Medicare makes daily payments based on 1 of 4 levels of hospice care. All hospice care and services offered to patients and their families must follow an individualized written plan of care that meets the patient’s needs. Our hospice service revenue is subject to certain limitations on payments from Medicare. We are subject to an inpatient cap limit and an overall Medicare payment cap for each provider number. We monitor these caps on a provider-by-provider basis and estimate amounts due back to Medicare if we estimate a cap has been exceeded. If applicable, we record these cap adjustments as a reduction to revenue. Medicaid is operated by individual states with the financial participation of the federal government. The states in which we operate currently use prospective cost–based reimbursement systems. Under cost–based reimbursement systems, the skilled nursing facility is reimbursed for the reasonable direct and indirect allowable costs it incurred in a base year in providing routine resident care services as defined by the program. Private pay, managed care, and other payment sources include commercial insurance, individual patient funds, managed care plans and the Veterans Administration. Private paying patients, private insurance carriers and the Veterans Administration generally pay based on the healthcare center's charges or specifically negotiated contracts. For private pay patients in skilled nursing, assisted living and independent living facilities, the Company bills for room and board charges, with the remittance being due on receipt of the statement and generally by the 10th day of the month the services are performed. Certain managed care payors for homecare services pay on a per-visit basis. This revenue is recorded on an accrual basis based upon the date of services at amounts equal to its established or estimated per-visit rates. 14 Table of Contents State Relief Supplemental Funding The Company received supplemental Medicaid payments from various states. The funding generally incorporates specific use requirements primarily for direct patient care including labor related expenses or various patient care related expenses. We have recorded $ 1,784,000 and $ 1,872,000 in net patient revenues for these supplemental Medicaid payments for the three months ended March 31, 2026 and 2025, respectively. Third Party Payors Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Noncompliance with such laws and regulations can be subject to regulatory actions including fines, penalties, and exclusion from the Medicare and Medicaid programs. We believe that we are following all applicable laws and regulations. Medicare and Medicaid program revenues, as well as certain Managed Care program revenues, are subject to audit and retroactive adjustment by government representatives or their agents. Settlements with third -party payors for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and the Company’s historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known, or as years are settled or are no longer subject to such audits, reviews, and investigations. We believe that any differences between the net revenues recorded, and final determination will not materially affect the consolidated financial statements. We have made provisions of approximately $ 14,062,000 and $ 13,739,000 as of March 31, 2026 and December 31, 2025, respectively, for various Medicare, Medicaid, and Managed Care claims reviews and current and prior year cost reports. Note 4 – Other Revenues Other revenues are outlined in the table below. Revenues from rental income include health care real estate properties owned by us and leased to third party operators. Revenues from management and accounting services include fees provided to manage and provide accounting services to other healthcare operators. Revenues from insurance services include premiums for workers’ compensation and professional liability insurance policies that our wholly owned insurance subsidiaries have written for certain healthcare operators to which we provide management or accounting services. "Other" revenues include miscellaneous health care related earnings (in thousands) . Three Months Ended March 31 2026 2025 Rental income $ 6,500 $ 6,450 Management and accounting services fees 4,310 4,423 Insurance services 788 814 Other 418 403 Total other revenues $ 12,016 $ 12,090 Rental Income The Company leases real estate assets consisting of skilled nursing facilities and assisted living facilities to third party operators. Additionally, we sublease four Florida skilled nursing facilities included in our lease from National Health Investors (“NHI”) as noted in Note 7 – Long Term Leases. NHI is a publicly-traded real estate investment trust. Mr. Robert G. Adams, non-executive Chairman of the NHC Board, also serves on the Board of Directors of NHI. Management Fees from National Health Corporation We manage five skilled nursing facilities owned by National Health Corporation (“National”). For the three months ended March 31, 2026 and 2025, we recognized management fees and interest on management fees of $ 1,407,000 and $ 1,408,000 , respectively, for these centers. 15 Table of Contents Insurance Services For workers’ compensation insurance services, the premium revenues reflected in the interim condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 were $ 484,000 and $ 525,000 , respectively. Associated losses and expenses including those for self-insurance are included in the interim condensed consolidated statements of operations as "Salaries, wages and benefits." For professional liability insurance services, the premium revenues reflected in the interim condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 were $ 304,000 and $ 289,000 , respectively. Associated losses and expenses including those for self–insurance are included in the interim condensed consolidated statements of operations as "Other operating costs and expenses". Note 5 – Non – Operating Income Non–operating income is comprised of the following (in thousands) : Three Months Ended March 31 2026 2025 Dividends and net realized gains and losses on sales of securities $ 1,910 $ 1,954 Interest income 2,193 2,125 Equity in losses of unconsolidated investments ( 346 ) - Total non-operating income $ 3,757 $ 4,079 Note 6 – Business Segments The Company has two reportable operating segments: ( 1 ) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and ( 2 ) homecare and hospice services. These reportable operating segments are consistent with information used by the Company’s Chief Executive Officer, as chief operating decision maker (“CODM”), to assess performance and allocate resources. The Company also reports an "all other" category that includes revenues from rental income, management and accounting services fees, insurance services, and costs of the corporate office. The Company’s CODM evaluates performance including pretax earnings and allocates capital resources to each segment based on an operating model that is designed to improve the quality of patient care and profitability of the Company while enhancing long-term shareholder value. The CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below. 16 Table of Contents The following tables set forth the Company’s unaudited interim condensed consolidated statements of operations by business segment (in thousands ): Three Months Ended March 31, 2026 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 330,330 $ 39,475 $ - $ 369,805 Other revenues 386 - 11,630 12,016 Net operating revenues 330,716 39,475 11,630 381,821 Costs and expenses: Salaries, wages, and benefits 197,092 24,655 13,327 235,074 Other operating 81,080 6,500 3,657 91,237 Rent 9,085 625 1,933 11,643 Depreciation and amortization 10,412 130 1,072 11,614 Total costs and expenses 297,669 31,910 19,989 349,568 Income/(loss) from operations 33,047 7,565 ( 8,359 ) 32,253 Non-operating income - - 3,757 3,757 Interest expense ( 269 ) - - ( 269 ) Unrealized gains on marketable equity securities - - 9,074 9,074 Income before income taxes $ 32,778 $ 7,565 $ 4,472 $ 44,815 Three Months Ended March 31, 2025 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 325,478 $ 36,129 $ - $ 361,607 Other revenues 373 - 11,717 12,090 Net operating revenues 325,851 36,129 11,717 373,697 Costs and expenses: Salaries, wages, and benefits 192,437 22,404 13,289 228,130 Other operating 81,870 7,258 3,329 92,457 Rent 8,834 608 1,923 11,365 Depreciation and amortization 10,062 130 786 10,978 Total costs and expenses 293,203 30,400 19,327 342,930 Income/(loss) from operations 32,648 5,729 ( 7,610 ) 30,767 Non-operating income - - 4,079 4,079 Interest expense ( 2,106 ) - - ( 2,106 ) Unrealized gains on marketable equity securities - - 10,982 10,982 Income before income taxes $ 30,542 $ 5,729 $ 7,451 $ 43,722 17 Table of Contents Note 7 – Long-Term Leases Operating Leases At March 31, 2026, we lease from NHI the real property of 32 skilled nursing facilities and three independent living centers under one lease agreement. As part of the lease agreement, we sublease four Florida skilled nursing facilities to a third -party operator. See Note 17 – Subsequent Event for further discussion of the lease and our purchase of the NHI real estate. The lease includes base rent plus a percentage rent. The annual base rent is $ 31,975,000 in 2026. The percentage rent is based on a quarterly calculation of revenue increases and is payable on a quarterly basis. Total facility rent expense to NHI was $ 10,103,000 and $ 9,911,000 for the three months ended March 31, 2026 and 2025, respectively. Minimum Lease Payments The following table summarizes the maturity of our operating lease liabilities as of March 31, 2026 ( in thousands ): Operating Leases 2027 $ 27,518 2028 2,675 2029 2,124 2030 1,853 2031 1,553 Thereafter 10,008 Total minimum lease payments 45,731 Less: amounts representing interest ( 6,417 ) Present value of future minimum lease payments 39,314 Less: current portion ( 26,018 ) Noncurrent lease liabilities $ 13,296 18 Table of Contents Note 8 – Earnings per Share Basic net income per share is computed based on the weighted average number of common shares outstanding for each period presented. Diluted net income per share reflects the potential dilution that would have occurred if securities to issue common stock were exercised, converted, or resulted in the issuance of common stock that would have then shared in our earnings. The following table summarizes the earnings and the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands, except for share and per share amounts): Three Months Ended March 31 2026 2025 Basic: Weighted average common shares outstanding 15,541,634 15,438,306 Net income attributable to National HealthCare Corporation $ 35,857 $ 32,205 Earnings per common share, basic $ 2.31 $ 2.09 Diluted: Weighted average common shares outstanding 15,541,634 15,438,306 Effects of dilutive instruments 228,873 137,446 Weighted average common shares outstanding 15,770,507 15,575,752 Net income attributable to National HealthCare Corporation $ 35,857 $ 32,205 Earnings per common share, diluted $ 2.27 $ 2.07 For the three months ended March 31, 2026 and 2025, 250,250 and 493,249 stock options, respectively, were excluded from the calculation of diluted weighted average shares of common stock outstanding because the inclusion of these securities would have an anti-dilutive impact. Note 9 – Investments in Marketable Securities Our investments in marketable equity securities are carried at fair value with the changes in unrealized gains and losses recognized in our results of operations at each measurement date. Our investments in marketable debt securities are classified as available for sale securities and carried at fair value with the unrealized gains and losses recognized through accumulated other comprehensive income at each measurement date. Any credit-related decline in fair market values below the amortized cost of our available for sale debt securities are recorded in our results of operations through an allowance for credit losses. Realized gains and losses from securities sales are recognized in results of operations upon disposition of the securities using the specific identification method on a trade date basis. Refer to Note 10 – Fair Value Measurements for a description of the Company's methodology for determining the fair value of marketable securities. Marketable securities consist of the following (in thousands) : March 31, 2026 December 31, 2025 Amortized Cost Fair Value Amortized Cost Fair Value Investments available for sale: Marketable equity securities $ 30,176 $ 172,826 $ 30,176 $ 162,972 Restricted investments available for sale: Marketable equity securities 13,311 16,624 13,104 17,197 Corporate debt securities 62,213 61,987 58,458 58,898 Asset-based securities 17,144 16,475 16,886 16,236 U.S. Treasury securities 42,367 41,468 43,384 42,836 State and municipal securities 2,906 2,902 5,282 5,323 $ 168,117 $ 312,282 $ 167,290 303,462 19 Table of Contents Included in the marketable equity securities are the following (in thousands, except share amounts): March 31, 2026 December 31, 2025 Shares Cost Fair Value Shares Cost Fair Value NHI Common Stock 1,630,642 $ 24,734 $ 131,854 1,630,642 $ 24,734 $ 124,532 The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows (in thousands) : March 31, 2026 December 31, 2025 Cost Fair Value Cost Fair Value Maturities: Within 1 year $ 18,659 $ 18,314 $ 14,309 $ 14,236 1 to 5 years 64,175 63,034 69,316 68,390 6 to 10 years 40,397 40,114 40,385 40,667 Over 10 years 1,399 1,370 - - $ 124,630 $ 122,832 $ 124,010 $ 123,293 Gross unrealized gains related to marketable equity securities are $ 146,697,000 and $ 137,436,000 as of March 31, 2026 and December 31, 2025, respectively. Gross unrealized losses related to marketable equity securities are $ 734,000 and $ 547,000 as of March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, the Company recognized net unrealized gains of $ 9,074,000 and $ 10,982,000 , respectively, for the changes in fair market value of the marketable equity securities in the interim condensed consolidated statements of operations. Gross unrealized gains related to available for sale marketable debt securities are $ 691,000 and $ 1,464,000 as of March 31, 2026 and December 31, 2025, respectively. Gross unrealized losses related to available for sale marketable debt securities are $ 2,489,000 and $ 2,181,000 as of March 31, 2026 and December 31, 2025, respectively. The Company’s unrealized losses in our available for sale marketable debt securities were determined to be non-credit related. The Company has not recognized any credit related impairments for the three months ended March 31, 2026 and 2025. For the marketable securities in gross unrealized loss positions, (a) it is more likely than not that the Company will not be required to sell the investment securities before recovery of the unrealized losses, and (b) the Company expects that the contractual principal and interest will be received on the investment securities. Proceeds from the sale of available for sale marketable securities during the three months ended March 31, 2026 and 2025 were $ 10,284,000 and $ 12,288,000 , respectively. Investment gains of $ 173,000 and $ 241,000 were realized on these sales during the three months ended March 31, 2026 and 2025, respectively. Note 10 – Fair Value Measurements The accounting standard for fair value measurements provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. Fair value is defined as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. This accounting standard establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs that may be used to measure fair value: Level 1 – The valuation is based on quoted prices in active markets for identical instruments. Level 2 – The valuation is based on observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model–based valuation techniques for which all significant assumptions are observable in the market. Level 3 – The valuation is based on unobservable inputs that are supported by minimal or no market activity and that are significant to the fair value of the instrument. Level 3 valuations are typically performed using pricing models, discounted cash flow methodologies, or similar techniques that incorporate management’s own estimates of assumptions that market participants would use in pricing the instrument, or valuations that require significant management judgment or estimation. 20 Table of Contents A financial instrument’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The following table summarizes fair value measurements by level at March 31, 2026 and December 31, 2025 for assets and liabilities measured at fair value on a recurring basis (in thousands) : Fair Value Measurements Using March 31, 2026 Fair Value Quoted Prices in Active Markets For Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents $ 85,526 $ 85,526 $ – $ – Restricted cash and cash equivalents 20,802 20,802 – – Marketable equity securities 189,450 189,450 – – Corporate debt securities 61,987 45,841 16,146 – Asset–backed securities 16,475 – 16,475 – U.S. Treasury securities 41,468 41,468 – – State and municipal securities 2,902 – 2,902 – Total financial assets $ 418,610 $ 383,087 $ 35,523 $ – Fair Value Measurements Using December 31, 2025 Fair Value Quoted Prices in Active Markets For Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Cash and cash equivalents $ 92,829 $ 92,829 $ – $ – Restricted cash and cash equivalents 19,358 19,358 – – Marketable equity securities 180,169 180,169 – – Corporate debt securities 58,898 45,948 12,950 – Asset–backed securities 16,236 – 16,236 – U.S. Treasury securities 42,836 42,836 – – State and municipal securities 5,323 877 4,446 – Total financial assets $ 415,649 $ 382,017 $ 33,632 $ – Note 11 – Goodwill and Other Intangible Assets At March 31, 2026, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of the review, there were no impairment indicators regarding the Company’s goodwill that required a quantitative test to be performed. However, our accounting estimates could materially change from period to period due to changing market factors. We will continue to monitor future events, changes in circumstances, and the potential impact thereof. If actual results are not consistent with our assumptions and estimates, we may be exposed to future goodwill impairment losses. At March 31, 2026, the following table represents the activity related to our goodwill by segment ( in thousands ): Inpatient Services Homecare and Hospice All Other Total January 1, 2026 $ 5,924 $ 164,554 $ – $ 170,478 Additions – – – – March 31, 2026 $ 5,924 $ 164,554 $ – $ 170,478 Indefinite-lived intangible assets consist of the following (in thousands) : March 31, 2026 December 31, 2025 Trade names $ 15,896 $ 15,896 Certificates of need 1,756 1,756 Licenses 2,212 2,212 Total $ 19,864 $ 19,864 21 Table of Contents Note 12 - Stock Repurchase Program During the three months ended March 31, 2026, the Company repurchased 97,720 shares of its common stock for a total cost of $ 16,321,000 . During the three months ended March 31, 2025, the Company repurchased 17,409 shares of its common stock for a total cost of $ 1,722,000 . The shares were funded from cash on hand and were cancelled and returned to the status of authorized but unissued. Note 13 – Stock – Based Compensation NHC recognizes stock–based compensation expense for all stock options granted over the requisite service period using the fair value at the date of grant using the Black–Scholes pricing model. Stock–based compensation totaled $ 1,280,000 and $ 1,027,000 for the three months ended March 31, 2026 and 2025, respectively. Stock–based compensation is included in “Salaries, wages and benefits” in the interim condensed consolidated statements of operations. At March 31, 2026, the Company had $ 13,723,000 of unrecognized compensation cost related to unvested stock–based compensation awards. This unrecognized compensation cost will be amortized over an approximate three -year period. Stock Options The following table summarizes the significant assumptions used to value the options granted for the three months ended March 31, 2026 and for the year ended December 31, 2025. March 31, 2026 December 31, 2025 Risk–free interest rate 3.5 % 4.1 % Expected volatility 28.7 % 27.0 % Expected life, in years 3.0 2.9 Expected dividend yield 1.7 % 2.8 % The following table summarizes our outstanding stock options for the three months ended March 31, 2026 and for the year ended December 31, 2025. Number of Shares Weighted Average Exercise Price Aggregate Intrinsic Value Options outstanding at January 1, 2025 631,242 $ 74.73 $ – Options granted 306,148 91.42 – Options exercised ( 202,281 ) 70.17 – Options cancelled ( 87,134 ) 85.94 – Options outstanding at December 31, 2025 647,975 82.53 – Options granted 256,159 156.51 – Options exercised ( 155,218 ) 79.05 – Options outstanding at March 31, 2026 748,916 $ 108.56 $ 38,299,147 Options exercisable at March 31, 2026 246,232 $ 75.15 $ 20,817,766 Options Outstanding March 31, 2026 Exercise Prices Weighted Average Exercise Price Weighted Average Remaining Contractual Life in Years 141,804 $ 53.94 - $ 71.64 $ 60.91 1.5 607,112 $ 90.62 - $ 157.13 119.69 4.1 748,916 $ 108.56 3.6 22 Table of Contents Note 14 – Income Taxes The Company's income tax provision as a percentage of our income before income taxes was 19.4 % and 26.1 % for the three months ended March 31, 2026 and 2025, respectively. Typically, these percentages vary from the U.S. federal statutory income tax rate of 21 % primarily due to state income taxes, excess tax benefits from stock-based compensation, benefits resulting from the lapsing of statute of limitations of items in our tax contingency reserve, and non-deductible expenses. For the three months ended March 31, 2026 and 2025, the excess tax over book deductions for stock compensation was the most significant reconciling item. Our quarterly income tax provision, and our estimate of our annual effective income tax rate, is subject to variation due to several factors, including volatility based on the amount of pre-tax income or loss. The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2022 (with certain state exceptions). Note 15 – Long-Term Debt Long–term debt consists of the following ( dollars in thousands ): Maturity March 31, 2026 December 31, 2025 Credit facility, interest payable monthly 2029 $ – $ 40,000 Less current portion – ( 7,500 ) Total long-term debt, less current portion $ – $ 32,500 On August 1, 2024, the Company entered into a $ 200,000,000 senior credit facility with a five -year term consisting of a $ 150,000,000 term facility and a $ 50,000,000 revolving line of credit (the “Credit Facility”). The Credit Facility is for general corporate purposes, including working capital and acquisitions. The loans bear interest at either (i) Term Secured Overnight Financing Rate (“SOFR”) for interest periods of one, three or six months, plus the applicable margin or, at NHC’s option, (ii) the Base Rate plus the applicable margin. The applicable margin is an interest rate per annum between 1.30 % and 1.65 % for Term SOFR loans and between .30% and .65% for Base Rate loans, depending upon the Company meeting certain conditions. The revolving line of credit contains a commitment fee equal to 0.25 % of the unused borrowing capacity. There are no amounts outstanding on the credit facility or the revolving line of credit at March 31, 2026. 23 Table of Contents Note 16 – Contingencies, Commitments and Other Matters Accrued Risk Reserves We have wholly-owned limited purpose insurance companies that insure risks related to workers’ compensation and professional liability insurance claims both for our owned and leased entities and certain of the entities to which we provide management or accounting services. The liability we have recognized for reported claims and estimates for incurred but unreported claims totals $ 126,500,000 and $ 121,595,000 at March 31, 2026 and December 31, 2025, respectively. The liability is included in accrued risk reserves in the interim condensed consolidated balance sheets and is subject to adjustment for actual claims incurred. It is possible that these claims plus unasserted claims could exceed our insurance coverages and our reserves, which could have a material adverse effect on our consolidated financial position, results of operations and cash flows. As a result of the terms of our insurance policies and our use of wholly owned limited purpose insurance companies, we have retained significant insurance risk with respect to workers’ compensation and general and professional liability. We consider the professional services of independent actuaries to assist us in estimating our exposures for claims obligations (for both asserted and unasserted claims) related to deductibles and exposures in excess of coverage limits, and we maintain reserves for these obligations. Such estimates are based on many variables including historical and statistical information and other factors. Workers ’ Compensation For workers’ compensation, we utilize a wholly–owned Tennessee domiciled property/casualty insurance company to write coverage for NHC affiliates and for third–party customers. Policies are written for a duration of twelve months and cover only risks related to workers’ compensation losses. All customers are companies which operate in the senior care industry. Business is written on a direct basis. General and Professional Liability Insurance and Lawsuits The senior care industry has experienced significant increases in both the number of personal injury/wrongful death claims and in the severity of awards based upon alleged negligence by skilled nursing facilities and their employees in providing care to residents. The Company has been, and continues to be, subject to claims and legal actions that arise in the ordinary course of business, including potential claims related to patient care and treatment. The defense of these lawsuits may result in significant legal costs, regardless of the outcome, and can result in large settlement amounts or damage awards. Additional insurance is purchased through third party providers that serve to supplement the coverage provided through our wholly owned captive insurance company. There is certain additional litigation incidental to our business, none of which, based upon information available to date, would be material to our financial position, results of operations, or cash flows. In addition, the long–term care industry is continuously subject to scrutiny by governmental regulators, which could result in litigation or claims related to regulatory compliance matters. 24 Table of Contents Governmental Regulations Laws and regulations governing Medicare, Medicaid and other federal healthcare programs are complex and subject to interpretation. Management believes that it is following all applicable laws and regulations in all material respects. However, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusions from the Medicare, Medicaid and other federal healthcare programs. Indemnities From time to time, the Company enters into certain types of contracts that contingently require it to indemnify parties against third -party claims. These contracts primarily include (i) certain real estate leases, under which the Company may be required to indemnify property owners or prior facility operators for post-transfer liabilities and other claims arising from the Company’s use of the applicable premises, (ii) operations transfer agreements, in which the Company agrees to indemnify past operators of facilities against certain liabilities arising from the transfer of the operation and/or the operation thereof after the transfer to the Company or its subsidiary, (iii) certain lending agreements, under which the Company may be required to indemnify the lender against various claims and liabilities, (iv) certain agreements by and between the Company and/or its subsidiaries or affiliates, and (v) certain agreements with the Company officers, directors and others, under which the Company may be required to indemnify such persons for liabilities arising out of the nature of their relationship to the Company and/or its subsidiaries and affiliates. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Note 17 – Subsequent Event On April 21, 2026, NHC entered into a Purchase and Sale Agreement to acquire the real estate of thirty-two skilled nursing facilities and three independent living facilities from NHI for the purchase price of $ 560 million. NHC currently operates and will continue to operate all of these facilities, except four Florida skilled nursing facilities. The four Florida skilled nursing facilities will continue to be subject to a third -party operator’s lease after the closing of the transaction. The facilities subject to the agreement are located in Alabama, Florida, Kentucky, Missouri, South Carolina, Tennessee, and Virginia. NHC operates multiple skilled nursing facilities, assisted living and independent living communities, as well as homecare and hospice operations within this geographic footprint. The acquisition will complement NHC’s current asset portfolio within these regions. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, including, but not limited to, the expiration or termination of the applicable waiting period and any extensions thereof under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.